StockData
Oragenics Inc logo

Oragenics Inc (OGEN) stock

OGENNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 1/30
$0.19−0.02 (-10.00%)

Close on Nov 18, 2026Market cap $852.76KP/E –Yield –

Oragenics shares outstanding

Diluted shares outstanding: the weighted share count used for earnings per share, adjusted for stock splits.

Oragenics's shares outstanding was 4M at Jun 30, 2026. For fiscal 2025 it was 2M, up 877.2% from the year before. Over ten years it grew 42.3% a year on average. The highest annual figure on record is 2M in fiscal 2023.

Annual shares outstanding

PeriodPeriod endValueChange
FY2025Dec 31, 20252M+877.2%
FY2024Dec 31, 20240M-90.2%
FY2023Dec 31, 20232M+12.0%
FY2022Dec 31, 20222M+3.2%
FY2021Dec 31, 20212M+99.7%
FY2020Dec 31, 20201M+33.7%
FY2019Dec 31, 20191M+224.3%
FY2018Dec 31, 20180M+164.7%
FY2017Dec 31, 20170M+10.4%
FY2016Dec 31, 20160M+21.7%
FY2015Dec 31, 20150M+1.4%
FY2014Dec 31, 20140M+25.6%
FY2013Dec 31, 20130M+62.3%
FY2012Dec 31, 20120M+210.2%
FY2011Dec 31, 20110M–

Quarterly shares outstanding

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 20264M+505.1%
Q1 FY2026Mar 31, 20264M+608.3%
Q4 FY2025Dec 31, 20254M+1845.9%
Q3 FY2025Sep 30, 20252M+933.9%
Q2 FY2025Jun 30, 20251M-79.1%
Q1 FY2025Mar 31, 20251M-76.6%
Q3 FY2024Sep 30, 20240M-90.8%
Q2 FY2024Jun 30, 20240M-92.5%
Q1 FY2024Mar 31, 20243M+58.6%
Q4 FY2023Dec 31, 20233M+17.1%
Q3 FY2023Sep 30, 20232M+21.1%
Q2 FY2023Jun 30, 20232M+4.4%
Q1 FY2023Mar 31, 20232M+10.1%
Q4 FY2022Dec 31, 20222M+10.2%
Q3 FY2022Sep 30, 20222M-2.9%
Q2 FY2022Jun 30, 20222M-2.9%
Q1 FY2022Mar 31, 20222M+12.8%
Q4 FY2021Dec 31, 20212M+71.2%
Q3 FY2021Sep 30, 20212M+94.8%
Q2 FY2021Jun 30, 20212M+121.9%
Q1 FY2021Mar 31, 20212M+123.2%
Q4 FY2020Dec 31, 20201M+47.3%
Q3 FY2020Sep 30, 20201M+29.4%
Q2 FY2020Jun 30, 20201M+13.2%
Q1 FY2020Mar 31, 20201M+51.0%
Q4 FY2019Dec 31, 20191M+286.7%
Q3 FY2019Sep 30, 20191M+665.1%
Q2 FY2019Jun 30, 20191M+824.0%
Q1 FY2019Mar 31, 20191M+519.6%
Q3 FY2018Sep 30, 20180M+142.3%
Q2 FY2018Jun 30, 20180M+22.3%
Q1 FY2018Mar 31, 20180M+1.5%
Q4 FY2017Dec 31, 20170M+0.2%
Q3 FY2017Sep 30, 20170M+0.3%
Q2 FY2017Jun 30, 20170M–
Q1 FY2017Mar 31, 20170M–
Q4 FY2016Dec 31, 20160M–
Q3 FY2016Sep 30, 20160M–

More Oragenics figures

See a number that looks wrong?